As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of ClearPoint Neuro, Inc. The largest reported stake is Bigger Michael's, at 8.12%. 13 filings are on record since July 17, 2025 (Schedule 13G/A, November 3, 2026).
Sell to companies like ClearPoint Neuro, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Bigger Capital Fund L P · Sole voting: 0 · Shared voting: 1,707,447 · Sole dispositive: 0 · Shared dispositive: 1,707,447 · SCHEDULE 13G/A, 2026-11-03
- · Reporting person: Mak Capital One LLC · Sole voting: 0 · Shared voting: 2,375,861 · Sole dispositive: 0 · Shared dispositive: 2,375,861 · SCHEDULE 13G/A, 2026-08-12
- · Holder: Bigger Michael · Percent: 7.45% · SCHEDULE 13G/A
- · Reporting person: BlackRock, Inc. · Sole voting: 2,087,782 · Shared voting: 0 · Sole dispositive: 2,118,912 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-27
- · Reporting person: MAK Capital Fund LP · Sole voting: 0 · Shared voting: 1,901,489 · Sole dispositive: 0 · Shared dispositive: 1,901,489 · SCHEDULE 13G/A, 2026-05-15
ClearPoint Neuro, Inc. has 13 Schedule 13D or 13G filings on record since 2025-07-17. 4 holders' latest filing reports 5% or more of common stock, $0.01 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 8.12% | 2,601,255 | SCHEDULE 13G/A, 2026-11-03 | 2026-09-30 | |
| Mak Capital One LLC | 7.8% | 2,375,861 | SCHEDULE 13G/A, 2026-08-12 | 2026-06-30 |
| BlackRock, Inc. | 7.1% | 2,118,912 | SCHEDULE 13G/A, 2026-07-27 | 2026-06-30 |
| MAK Capital Fund LP | 6.3% | 1,901,489 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind ClearPoint Neuro, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on ClearPoint Neuro, Inc. and the records around it.
ClearPoint Neuro, Inc. elsewhere on the record
- Form D filing Feb 2026
- Who owns it
Companies that share a holder
- MAK CAPITAL ONE LLC also filed stake reports on 3 other companies: PERMA FIX ENVIRONMENTAL SERVICES INC (Aug 2026), STANDARD BIOTOOLS INC. (Aug 2026), HEIDRICK & STRUGGLES INTERNATIONAL INC (Nov 2025)
- MAK Capital Fund LP also filed stake reports on 7 other companies: Comstock Inc. (Oct 2026), Autolus Therapeutics plc (May 2026), STANDARD BIOTOOLS INC. (May 2026)
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026), Neuraxis, INC (Aug 2026)
Watch ClearPoint Neuro, Inc.
Get an email when ClearPoint Neuro, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on ClearPoint Neuro, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ClearPoint Neuro, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ClearPoint Neuro, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Bigger Capital Fund L P | 0 | 1,707,447 | 0 | 1,707,447 | SCHEDULE 13G/A, 2026-11-03 |
| Bigger Capital Fund GP, LLC | 0 | 1,707,447 | 0 | 1,707,447 | SCHEDULE 13G/A, 2026-11-03 |
| District 2 Capital Fund LP | 0 | 315,808 | 0 | 315,808 | SCHEDULE 13G/A, 2026-11-03 |
| District 2 Capital LP | 0 | 315,808 | 0 | 315,808 | SCHEDULE 13G/A, 2026-11-03 |
| District 2 GP LLC | 0 | 315,808 | 0 | 315,808 | SCHEDULE 13G/A, 2026-11-03 |
| District 2 Holdings LLC | 0 | 315,808 | 0 | 315,808 | SCHEDULE 13G/A, 2026-11-03 |
| Bigger Michael | 55,000 | 2,546,255 | 55,000 | 2,546,255 | SCHEDULE 13G/A, 2026-11-03 |
| Patricia Winter | 167,000 | 0 | 167,000 | 0 | SCHEDULE 13G/A, 2026-11-03 |
| Mak Capital One LLC | 0 | 2,375,861 | 0 | 2,375,861 | SCHEDULE 13G/A, 2026-08-12 |
| MAK Capital Fund LP | 0 | 2,375,861 | 0 | 2,375,861 | SCHEDULE 13G/A, 2026-08-12 |
| Kaufman Michael A | 0 | 2,375,861 | 0 | 2,375,861 | SCHEDULE 13G/A, 2026-08-12 |
| BlackRock, Inc. | 2,087,782 | 0 | 2,118,912 | 0 | SCHEDULE 13G/A, 2026-07-27 |
| MAK Capital Fund LP | 0 | 1,901,489 | 0 | 1,901,489 | SCHEDULE 13G/A, 2026-05-15 |
| Mak Capital One LLC | 0 | 1,901,489 | 0 | 1,901,489 | SCHEDULE 13G/A, 2026-05-15 |
| Kaufman Michael A | 0 | 1,901,489 | 0 | 1,901,489 | SCHEDULE 13G/A, 2026-05-15 |
The latest filing identifies ClearPoint Neuro, Inc. by CUSIP 18507C103 and gives its principal executive office as 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA 92075 (SCHEDULE 13G/A, 2026-11-03).
What the percentages are based on
The following percentages are based on 32,054,268 shares of Common Stock outstanding as of October 21, 2026, based upon the Issuer's Form 10-Q filed with the Securities and Exchange Commission on October 28, 2026.Bigger Michael, SCHEDULE 13G/A, 2026-11-03
7.8% The calculation is based upon 2,375,861 shares of Common Stock beneficially owned as of 06/30/2026 and a total of 30,504,227 shares of Common Stock, $0.01 par value per share, outstanding as of July 27, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 3, 2026.Mak Capital One LLC, SCHEDULE 13G/A, 2026-08-12
6.3% The calculation is based upon 1,901,489 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 29,989,563 shares of Common Stock, $0.01 par value per share, outstanding as of May 7, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026.MAK Capital Fund LP, SCHEDULE 13G/A, 2026-05-15
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 5.6% | SCHEDULE 13G |
| 2025-07-29 | The Vanguard Group | 5.27% | SCHEDULE 13G |
| 2025-08-04 | Bigger Michael | 7.7% | SCHEDULE 13G/A |
| 2025-11-12 | Bigger Michael | 7.6% | SCHEDULE 13G/A |
| 2026-02-04 | Bigger Michael | 7.8% | SCHEDULE 13G/A |
| 2026-03-13 | MAK Capital Fund LP | 6.1% | SCHEDULE 13G |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-20 | Bigger Michael | 7.54% | SCHEDULE 13G/A |
| 2026-05-15 | MAK Capital Fund LP | 6.3% | SCHEDULE 13G/A |
| 2026-07-27 | BlackRock, Inc. | 7.1% | SCHEDULE 13G/A |
| 2026-08-04 | Bigger Michael | 7.45% | SCHEDULE 13G/A |
| 2026-08-12 | Mak Capital One LLC | 7.8% | SCHEDULE 13G/A |
| 2026-11-03 | Bigger Michael | 8.12% | SCHEDULE 13G/A |
Questions about who owns ClearPoint Neuro, Inc.
Who owns ClearPoint Neuro, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of ClearPoint Neuro, Inc.: Bigger Michael (8.12%, Schedule 13G/A, filed 2026-11-03), Mak Capital One LLC (7.8%, Schedule 13G/A, filed 2026-08-12), BlackRock, Inc. (7.1%, Schedule 13G/A, filed 2026-07-27) and MAK Capital Fund LP (6.3%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of ClearPoint Neuro, Inc.?
By the share each holder's latest filing reports, the largest holders of ClearPoint Neuro, Inc. on this page are Bigger Michael (8.12%), Mak Capital One LLC (7.8%) and BlackRock, Inc. (7.1%).
When did Bigger Michael buy into ClearPoint Neuro, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Bigger Michael on this page is the Schedule 13G/A, filed 2025-08-04, reporting 7.7%; its latest, Schedule 13G/A filed 2026-11-03, reports 8.12%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 13 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for ClearPoint Neuro, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 21, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| February 5, 2026 | Form D, private offering | $17.89M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for ClearPoint Neuro, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.